TITLE

Bulking up in generics

AUTHOR(S)
Mirasol, Feliza
PUB. DATE
March 2006
SOURCE
Chemical Market Reporter;3/13/2006, Vol. 269 Issue 10, p18
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the mergers and acquisitions (M&A) of companies in the generic drug industry worldwide. In 2000, leading consolidations were Novartis' Sandoz, Teva Pharmaceuticals and Merck KGaA. Decision Resources Inc. cited the factors driving the boom of M&A activity including cost pressures due to government price regulation, quests for size and economies of scale of companies and the need to access for new therapeutic areas and new technologies.
ACCESSION #
20204028

 

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics